Longitudinal assessment of growth and bone mineral accretion in prematurely born infants treated for chronic lung disease with dexamethasone.
about
The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systematic review of RCTsRelationship of tibial speed of sound and lower limb length to nutrient intake in preterm infants.Dietary long-chain polyunsaturated fatty acids minimize dexamethasone-induced reductions in arachidonic acid status but not bone mineral content in piglets.Effects of prematurity, intrauterine growth status, and early dexamethasone treatment on postnatal bone mineralisation.Antenatal treatment of a mother bearing a fetus with congenital adrenal hyperplasia.Postnatal glucocorticosteroid therapy for treatment and prevention of neonatal chronic lung disease.Current nutrition management of infants with chronic lung disease.Mitogen-inducible gene-6 partly mediates the inhibitory effects of prenatal dexamethasone exposure on endochondral ossification in long bones of fetal rats.Dietary 2-oxoglutarate prevents bone loss caused by neonatal treatment with maximal dexamethasone dose.Calcium, phosphorus and magnesium balance: FM 85 fortification of human milk does not meet mineral needs of extremely low birthweight infants.Short-term growth of premature infants treated with dexamethasone assessed by mini-knemometry.Dietary supplementation of arachidonic acid is associated with higher whole body weight and bone mineral density in growing pigs.Dexamethasone-induced abnormalities in growth and bone metabolism in piglets are partially attenuated by growth hormone with no synergistic effect of insulin-like growth factor-I.Nutritional status at 2 years in former infants with bronchopulmonary dysplasia influences nutrition and pulmonary outcomes during childhood.
P2860
Q24796431-8A7BD034-A6A4-4B92-877D-2BD7630B6C3BQ30479685-96FB8A63-6EA8-402E-A85D-B676660E3B7BQ30818247-9E817E57-692E-4885-8141-D13F324F5107Q30908909-EB99CE77-738B-464A-87BF-85E54D9668B7Q33905613-62CD9714-EE1A-4AF4-B2A2-118B528DBFEEQ34074665-3F6A9DBC-B81A-40E9-A182-5341E4DD4037Q36281789-C0209760-5FD6-43EF-A40B-F56490ABAABBQ37034768-B3780DC6-3F46-4A21-93FD-A0016B7C78C3Q41641382-BF819AA3-160C-4D7C-8A11-B9CA8CBBEFA1Q43963749-7B111F12-4870-42F3-B708-3EAC874C209BQ45129682-A1D278BF-1261-450F-9506-317DAA7669A5Q47239117-05BBDF15-DC37-4FE3-8325-CE94F36DA568Q47692068-A30AF52D-C91C-44A2-A923-6E4FE6F0C794Q51794769-219D63F1-499D-4146-8F47-0E4BCBA1A211
P2860
Longitudinal assessment of growth and bone mineral accretion in prematurely born infants treated for chronic lung disease with dexamethasone.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Longitudinal assessment of gro ...... ng disease with dexamethasone.
@en
Longitudinal assessment of gro ...... ng disease with dexamethasone.
@nl
type
label
Longitudinal assessment of gro ...... ng disease with dexamethasone.
@en
Longitudinal assessment of gro ...... ng disease with dexamethasone.
@nl
prefLabel
Longitudinal assessment of gro ...... ng disease with dexamethasone.
@en
Longitudinal assessment of gro ...... ng disease with dexamethasone.
@nl
P2093
P1476
Longitudinal assessment of gro ...... ng disease with dexamethasone.
@en
P2093
P304
P356
10.1016/S0378-3782(96)01783-5
P577
1997-02-01T00:00:00Z